Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9404248AGB9404248D0 (en) | 1994-03-05 | 1994-03-05 | Pharmaceutical formulations |
SK1132-96ASK113296A3 (en) | 1994-03-05 | 1995-03-02 | Adhesive free topical pharmaceutical formulation |
NZ281633ANZ281633A (en) | 1994-03-05 | 1995-03-02 | Topical wipe or wrap containing a non-steroidal anti-inflammatory drug (nsaid) in a 2-4c alcohol |
CZ962585ACZ258596A3 (en) | 1994-03-05 | 1995-03-02 | Topic pharmaceutical preparation without adhesive |
PL95316040APL316040A1 (en) | 1994-03-05 | 1995-03-02 | Pharmaceutic compositions |
PCT/EP1995/000791WO1995023596A1 (en) | 1994-03-05 | 1995-03-02 | Adhesive free topical pharmaceutical formulations |
JP7522708AJPH09509675A (en) | 1994-03-05 | 1995-03-02 | Pharmaceutical prescription |
EP95910550AEP0749301A1 (en) | 1994-03-05 | 1995-03-02 | Adhesive free topical pharmaceutical formulations |
AU18502/95AAU691583B2 (en) | 1994-03-05 | 1995-03-02 | Adhesive free topical pharmaceutical formulations |
ZA951781AZA951781B (en) | 1994-03-05 | 1995-03-03 | Pharmaceutical formulations |
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9404248AGB9404248D0 (en) | 1994-03-05 | 1994-03-05 | Pharmaceutical formulations |
Publication Number | Publication Date |
---|---|
GB9404248D0true GB9404248D0 (en) | 1994-04-20 |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9404248APendingGB9404248D0 (en) | 1994-03-05 | 1994-03-05 | Pharmaceutical formulations |
Country | Link |
---|---|
EP (1) | EP0749301A1 (en) |
JP (1) | JPH09509675A (en) |
AU (1) | AU691583B2 (en) |
CZ (1) | CZ258596A3 (en) |
GB (1) | GB9404248D0 (en) |
NZ (1) | NZ281633A (en) |
PL (1) | PL316040A1 (en) |
SK (1) | SK113296A3 (en) |
WO (1) | WO1995023596A1 (en) |
ZA (1) | ZA951781B (en) |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0858805A3 (en)* | 1997-02-13 | 1998-09-02 | National Research Institute of Chinese Medicine | Transdermal preparations of oxicams |
ES2275525T3 (en) | 1999-07-12 | 2007-06-16 | Capnia Incorporated | APPLIANCE TO RELIEF HEAD PAIN, RHINITIS AND OTHER COMMON AFFECTIONS |
US20070039615A1 (en) | 1999-11-08 | 2007-02-22 | Capnia, Incorporated | Methods and apparatus for treating rhinitis |
US20060172017A1 (en) | 1999-11-08 | 2006-08-03 | Capnia, Incorporated | Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
WO2004060347A2 (en)* | 2002-09-03 | 2004-07-22 | Transform Pharmaceuticals, Inc. | Pharmaceutical propylene glycol solvate compositions |
US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
JP4906233B2 (en) | 2002-03-01 | 2012-03-28 | ユニバーシティー オブ サウス フロリダ | Multi-component solid phase containing at least one active pharmaceutical ingredient |
CN100360117C (en)* | 2002-06-21 | 2008-01-09 | 转化医药公司 | Pharmaceutical compositions with improved dissolution |
GB0518769D0 (en)* | 2005-09-14 | 2005-10-19 | Medpharm Ltd | Topical formulations |
HU227970B1 (en) | 2007-07-10 | 2012-07-30 | Egis Gyogyszergyar Nyrt | Pharmaceutical compositions containing silicones of high volatility |
MX2011004454A (en)* | 2008-10-31 | 2011-08-15 | Moberg Derma Ab | Topical composition comprising a combination of at least two penetration enhancing agents. |
TR200907179A1 (en) | 2009-09-18 | 2011-04-21 | Sanovel İlaç San. Ve Ti̇c. A. Ş. | Flurbiprofen and muscle relaxant combinations |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
EP2468270A1 (en)* | 2010-12-21 | 2012-06-27 | GALENpharma GmbH | (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases |
HUE046750T2 (en) | 2011-05-03 | 2020-03-30 | Aponia Laboratories Inc | Transdermal compositions of ibuprofen and methods of use thereof |
EP2793855B1 (en) | 2011-12-23 | 2015-12-16 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Flurbiprofen formulations |
WO2013095319A2 (en) | 2011-12-23 | 2013-06-27 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Formulations of flurbiprofen and diacerein |
EP2793856B1 (en) | 2011-12-23 | 2015-12-16 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Orally-disintegrating formulations of flurbiprofen |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US11007161B1 (en) | 2014-12-31 | 2021-05-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films |
US10596117B1 (en) | 2014-12-31 | 2020-03-24 | Eric Morrison | Lipoleosomes as carriers for aromatic amide anesthetic compounds |
US10561627B2 (en) | 2014-12-31 | 2020-02-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
JP7653218B2 (en) | 2016-05-05 | 2025-03-28 | アクエスティブ セラピューティクス インコーポレイテッド | Enhanced Delivery Epinephrine Compositions |
WO2019113625A1 (en)* | 2017-12-11 | 2019-06-20 | Meat & Livestock Australia Ltd | Transdermal analgesic formulation |
ES2835399B2 (en)* | 2019-12-20 | 2022-03-23 | Univ Jaen | Procedure for obtaining a textile material carrying molecules of pharmacological interest and material thus obtained |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB119646A (en)* | 1917-10-05 | 1919-07-04 | Hendrik Johannes Chr Hengeveld | Wadding for Curing Rheumatism. |
GB1191645A (en)* | 1966-10-05 | 1970-05-13 | American Gage & Mach | Recording Apparatus |
GB2075837B (en)* | 1980-05-14 | 1984-03-14 | Hisamitsu Pharmaceutical Co | Topical pharmaceutical gel containing anti-inflammatory analgesic agents |
JPS57140711A (en)* | 1981-02-26 | 1982-08-31 | Teika Seiyaku Kk | Poultice for anti-inflammatory and analgesic use and its preparation |
JPH0662401B2 (en)* | 1985-04-25 | 1994-08-17 | 久光製薬株式会社 | Ketoprofen-containing patch |
DE3522550A1 (en)* | 1985-06-24 | 1987-01-02 | Klinge Co Chem Pharm Fab | SPRAYABLE PHARMACEUTICAL PREPARATION FOR TOPICAL APPLICATION |
JPS6399866A (en)* | 1986-10-17 | 1988-05-02 | 石田 賢司 | Lint cloth having drug coated surface and its production |
JP2570342B2 (en)* | 1987-12-01 | 1997-01-08 | 日産化学工業株式会社 | External solution |
EP0331382B1 (en)* | 1988-02-29 | 1992-09-09 | Pfizer Inc. | Transdermal flux enhancing compositions |
US5061724A (en)* | 1989-07-18 | 1991-10-29 | Sheldon Gertner | Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis |
US5093133A (en)* | 1990-01-24 | 1992-03-03 | Mcneil-Ppc, Inc. | Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
AU8927191A (en)* | 1990-10-05 | 1992-04-28 | Analgesic Associates | Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen |
JPH1143831A (en)* | 1997-07-22 | 1999-02-16 | Murata Mach Ltd | Spinning device |
Publication number | Publication date |
---|---|
SK113296A3 (en) | 1997-05-07 |
CZ258596A3 (en) | 1996-12-11 |
AU1850295A (en) | 1995-09-18 |
ZA951781B (en) | 1995-09-05 |
PL316040A1 (en) | 1996-12-23 |
NZ281633A (en) | 1998-04-27 |
EP0749301A1 (en) | 1996-12-27 |
WO1995023596A1 (en) | 1995-09-08 |
JPH09509675A (en) | 1997-09-30 |
AU691583B2 (en) | 1998-05-21 |
Publication | Publication Date | Title |
---|---|---|
AP9500733A0 (en) | Pharmaceutical formulations | |
EG23826A (en) | Pharmaceutical formulations | |
GB9404248D0 (en) | Pharmaceutical formulations | |
GB9523752D0 (en) | Pharmaceutical formulations | |
GB9407386D0 (en) | Pharmaceutical formulation | |
GB9402203D0 (en) | Pharmaceutical formulation | |
IL112521A0 (en) | Pharmaceutical formulation | |
GB9405856D0 (en) | Pharmaceutical formulation | |
GB9416599D0 (en) | Pharmaceutical formulation | |
GB9408053D0 (en) | Pharmaceutical preparation | |
GB9311030D0 (en) | Pharmaceutical formulations | |
GB9323399D0 (en) | Pharmaceutical formulations | |
ZA96392B (en) | Pharmaceutical formulations | |
GB9413542D0 (en) | Pharmaceutical formulations | |
GB9500978D0 (en) | Pharmaceutical formulations | |
GB9417953D0 (en) | Pharmaceutical formulations | |
GB9408163D0 (en) | Pharmaceutical formulations | |
GB9408151D0 (en) | Pharmaceutical formulations | |
GB9401738D0 (en) | Pharmaceutical formulations | |
GB9408162D0 (en) | Pharmaceutical formulations | |
GB9408161D0 (en) | Pharmaceutical formulations | |
GB9426113D0 (en) | Pharmaceutical formulations | |
GB9414216D0 (en) | Pharmaceutical formulations | |
GB9408164D0 (en) | Pharmaceutical formulations | |
GB9606372D0 (en) | Pharmaceutical formulations |